Clinical Trial Update: Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating the safety and tolerability of inhaled carbon monoxide in kidney transplant patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Inhaled carbon monoxide (carbon monoxide inhalation)

Snippet

Sponsor: Mallinckrodt | Conditions: Kidney Transplantation | Phase 2 | Status: WITHDRAWN